LaNova Medicines is based in Shanghai, China. It has raised $42M in total funding. Latest round: Series C.
LaNova Medicines is based in Shanghai, China. LaNova Medicines has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in October 2024. The round record for LaNova Medicines runs through 2024; nothing later has been disclosed. Investors on record include Sino Biopharmaceuticals Limited, Pudong Innovation Investment, Zhangjiang Haoheng, Qiming Venture Partners, Shanghai Healthcare Capital. 5 distinct backers are named across the disclosed rounds.
Totals shown for LaNova Medicines aggregate every disclosed round on file. To see how that compares, browse the companies in Shanghai and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026